
ARTHUR J. GALLAGHER & CO. (AJG), a large-cap growth stock in the Insurance sector, received a 56% rating from Validea's 'Patient Investor' model, which is based on Warren Buffett's strategy and targets firms with predictable profitability, low debt, and reasonable valuations. This score falls below the 80% threshold for 'some interest,' despite AJG passing criteria for earnings predictability, return on assets, free cash flow, and use of retained earnings, while failing on return on equity, initial rate of return, and expected return.
ARTHUR J. GALLAGHER & CO. (AJG), a large-cap growth stock in the Insurance sector, received a 56% rating from Validea's "Patient Investor" model, which is based on Warren Buffett's strategy. This score falls below the 80% threshold for "some interest" and the 90% for "strong interest," indicating a lack of high conviction from this long-term, value-oriented approach that prioritizes predictable profitability, low debt, and reasonable valuations. AJG demonstrated fundamental strengths, passing criteria for earnings predictability, return on assets, free cash flow, and the effective use of retained earnings. However, the company failed on critical valuation and profitability metrics, specifically return on equity, initial rate of return, and expected return, suggesting potential concerns regarding its intrinsic value or future profitability relative to its current price. Share repurchase activity was deemed neutral. The overall "mixed" sentiment and slightly negative per-ticker sentiment for AJG, despite some strong fundamental passes, underscore the model's emphasis on valuation. The 56% score implies that while AJG possesses desirable characteristics, its current market pricing or certain profitability aspects do not align with the strict criteria for a high-conviction "Patient Investor" selection.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mixed
Sentiment Score
-0.10
Ticker Sentiment